Patients with KRAS wild-type (WT) genomics achieved significant improvement in median overall survival (mOS) when treated with elraglusib plus ...

Final Bria-IMT™ Phase 2 data show 55% >1 year and 27% >2-year survival in heavily pre-treated metastatic breast cancer (MBC) ...

Ariane De Ganck, Chief Scientific Officer at Ardena Scientific leadership for complex development.Ariane De Ganck, PhD, ...

Chris Van Gorder, president and chief executive of Scripps Health, was honored with the Partner in Care Foundation’s 2026 ...

Detailed price information for Hive Digital Technologies Ltd (HIVE-Q) from The Globe and Mail including charting and trades.

In recent days, Tempus AI announced a string of oncology-focused product advances, including FDA approval of its xT CDx tumor-only sequencing assay, major upgrades to its AI-enabled Next and Hub ...

Connect Life Sciences (CLS) is pleased to announce the appointment of Megan Driscoll as Executive Chairman of its Board of Directors. CLS, a portfolio company of Argosy Healthcare Partners (AHP), is a ...

Nothing about long Covid adds up. All of this is very strange. Stranger still are patients’ stories of astonishing recoveries from severe long Covid, achieved entirely outside mainstream medicine. The ...

Ahead of Global Running Day on June 3, Pulsetto, the leading wearable vagus nerve stimulation (VNS) brand, today released results from its HOKA Hackney Half Marathon Runner Recovery Project, a ...

Cancer immunotherapy has profoundly changed the therapeutic landscape of several solid tumors, yet only a subset of patients derives durable clinical ...

A new PET tracer targeting carbonic anhydrase IX (CAIX) has demonstrated exceptional sensitivity and high tumor-to-background ...

Researchers from VIB, VUB, and an international network of collaborators have created the most comprehensive single-cell ...